FDCDDQ
PRQR icon

Federation des caisses Desjardins du Quebec’s ProQR Therapeutics PRQR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,496
Closed -$13.6K – 2603
2024
Q3 		$13.6K Buy
+7,496
New +$14.1K ﹤0.01% 1786

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PRQR Position: Q4 2024 in Review

Federation des caisses Desjardins du Quebec sold out of ProQR Therapeutics (PRQR) in Q4 2024, closing a stake of 7,496 shares — an estimated $13.6K sold.

Federation des caisses Desjardins du Quebec first reported a position in PRQR in Q3 2024 and held it in 1 quarter. The position peaked at $13.6K in Q3 2024. 77 funds tracked by Wall St. Rank hold PRQR as of Q4 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining ProQR Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 7,496 ProQR Therapeutics shares in Q4 2024, an estimated $13.6K.
  • Federation des caisses Desjardins du Quebec first reported a position in ProQR Therapeutics in Q3 2024 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's ProQR Therapeutics position peaked at $13.6K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2024, filed 14 Feb 2025.